Figure 4From: Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1Immunostaining of original patient tumor, low and high passage KCI-MENG1 cells, and subcutaneous xenograft tumor. The original patient-derived tumor showed moderate immunoreactivity for E-cadherin which was maintained in all in vitro and in vivo models. Scale bar 50 µm.Back to article page